Clinical Trials · NCT02845219
A Trial Investigating the Influence of Oral Semaglutide on Pharmacokinetics of Ethinylestradiol and Levonorgestrel in an Oral Contraceptive Combination Drug in Healthy Postmenopausal Females
- Phase
- Phase 1
- Recruitment status
- Completed
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 25
- Start date
- Jul 2016
- Locations
- 1 site, Germany
- Primary endpoint
- Area under the ethinylestradiol plasma concentration-time curve during a dosing interval (0-24 hours) at steady state